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Abstract
Background: GTPase‐activating proteins (GAPs) accelerate the rate of hydrolysis
of GTP bound to small GTPases, thereby limiting the prevalence and concentra-
tion of the active, GTP‐bound form of these proteins. The large number of poten-
tial GAPs acting on members of the Rho family of small GTPases raises the
question of specificity or redundancy.
Results: In this review, we summarize experimental data obtained on the role of
Rho family GAPs in neutrophils, highlight cases where more than one GAP is
involved in a physiological function and show examples that GAPs can be
involved not only in termination but also in initiation of cellular processes. We
demonstrate that the expression‐level regulation of GAPs may also occur in short‐
living cells such as neutrophils. Finally, we provide insight into the existence and
structure of molecular complexes in which Rho family GAPs are involved.
Conclusion: GAPs play more complex and varied roles than being simple termi-
nators of cellular processes.
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1 | INTRODUCTION
GTP‐binding proteins are regarded as cellular time
switches. In their active, GTP‐bound form, they are able to
react with specific target proteins but their endogenous
GTP‐hydrolysing capability limits the duration of the regu-
lated reaction.1 Timing is determined by the rate of GTP
hydrolysis, which is an inherent property of the given pro-
tein. In case of small GTPases (smg), the GTP hydrolytic
rate is several orders of magnitude slower than the typical
value measured for the alpha subunits of heterotrimeric G
proteins. Without any further regulation, processes regu-
lated by smgs would be characterized by very poor
dynamic properties.1
GTPase‐activating proteins (GAPs) significantly acceler-
ate GTP hydrolysis by contributing a critical amino acid to
the catalytic site.1 GAPs comprise a core region of approx.
20 kDa where the GTP‐binding and hydrolysing capacity
resides, surrounded by any number and type of other inter-
acting domains.1,2 On the basis of the conserved sequence
of the GTP‐hydrolysing domain, the potential number of
GAPs can be estimated from the genome sequence of dif-
ferent species. The number of putative GAPs acting on
members of the different subfamilies of smgs is variably
high. The situation is especially complex in case of the
Rho subfamily, where the potential GAPs outnumber the
smgs by a factor of 3 or 4.3 The large number of the regu-
latory proteins, their varied domain structure and different
substrate specificity raise a long series of questions. This
review discusses the complexity of the Rho family of
GAPs revealed in neutrophilic granulocytes.
2 | HOW MANY RHO FAMILY GAPS
ARE IN A NEUTROPHIL?
In an earlier in silico study, we analysed the distribution of
54 Rho family GAPs in approx. 50 different human tissues
on the basis of expressed sequence tag (EST) databases. In
addition, we also searched publicly available data of
microarray experiments and identified the expressed Rho
family GAPs in approx. 20 tissues or cell types.2 The
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concordant result of the two searches was that in all inves-
tigated tissues a large number of Rho family GAPs may be
expressed.
For neutrophils, we found two series of microarray data
and they indicated expression of approx. 20 different pro-
teins at variable levels. Not surprisingly, the Rho family
GAP profile of macrophages was very similar to that of
neutrophils, whereas in lymphocytes, almost all investi-
gated proteins seemed to be expressed, several of them at
very high intensity.
Experimental data obtained on isolated cells or in genet-
ically modified animals indicate the involvement of at least
11 different Rho family GAPs in various neutrophil func-
tions (Table 1).
3 | HOW MANY RHO FAMILY GAPS
ARE INVOLVED IN ORGANIZING A
FUNCTION?
Rho family smgs are involved in several vital functions of
neutrophils. P67phox, one of the essential subunits of
NADPH oxidase, is a direct target of Rac1 and Rac2.22,23
In this way, the activity of these smgs determines the rate
and duration of superoxide production. Direct targets of
Rho (mDia), Rac (PAK and WAVE) and Cdc42 (WASP)
are involved in regulation of actin polymerization, whereas
Rho regulates myosin contractility via its direct target Rho
kinase (ROCK).24 Thus, all three major members of the
Rho subfamily of smgs are directly involved in the organi-
zation of shape changes, adherence, motility such as
chemotaxis or migration through the vessel wall, and
phagocytosis, all basic neutrophil functions. In addition,
Rho family members are also indirectly involved in the
regulation of all these neutrophil functions via their effects
on different lipid kinases, for example PI3K and PI4P‐5‐
kinase.25
There are a few examples indicating that more than one
Rho family GAP may be involved in the regulation of the
same molecular process. In an acellular system, Rho family
GAPs associated with the cell membrane of human neu-
trophils have been specifically depleted by antibodies, and
changes in the NADPH oxidase activity were followed.6
Extraction of p50RhoGAP (Cdc42GAP) or ARHGAP25
TABLE 1 Smg specificity and cellular functions of Rho family GAPs investigated in neutrophils
Rho family GAP Smg specificity Species Regulated function References
ARAP3/CENTD3 RhoA (Arf6) Mouse Adhesion, spreading, granule release,
chemotaxis
[4]
ARHGAP25 Rac Mouse Transendothelial migration [5]
Human (cell free) NADPH oxidase [6]
Human/cell culture Phagocytosis Actin polymerization [7,8]
ARHGAP1/Cdc42GAP/
p50RhoGAP/RHOGAP1
Rho/Rac/
Cdc42
Human (cell free) NADPH oxidase [6,9]
Mouse Motility, migration [10]
ARHGAP35/p190‐A
RhoGAP/GRLF1
Rac/Rho Human (cell free) NADPH oxidase [6,9,11]
Mouse No role in integrin‐mediated neutrophil
functions and in rheumatoid arthritis
[12]
Human β2 integrin activation [13]
ARHGAP46/GMIP RhoA Mouse/human Azurophilic granule exocytosis. [14]
ARHGAP15 Rac Mouse Migration, NADPH oxidase, phagocytosis,
abdominal sepsis, retention in bone marrow
[15,16]
Human/cell culture Migration, actin polymerization [17]
ARHGAP13/srGAP1 Cdc42 Mouse/human Neutrophil chemotaxis [18]
BCR/ABR Rac/Cdc42 Mouse (double knockout) Acute inflammatory responses [19]
BCR Rac/Cdc42 Human (cell free) NADPH oxidase [9]
Mouse Septic shock
NADPH oxidase
[20]
ARHGAP12 Rac Human/cell culture Actin polymerization [8]
ARHGAP43/SH3BP1 Rac Human/cell culture Actin polymerization [8]
ARHGAP21/
ARHGAP10
Cdc42/RhoC Mouse/human Hematopoietic stem and progenitor cell
development
[21]
Data are based on PubMed search.
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resulted in significant increase in superoxide production.
Moreover, the two alterations were additive, showing that
under resting conditions, both proteins were actively down-
regulating Rac activity. In contrast, depletion of p190‐A
(ARHGAP35) did not affect NADPH oxidase activity. The
latter finding suggests selectivity in the action of Rho fam-
ily GAPs.
A more complex situation has been revealed in the
phagocytic process. In human neutrophils, we have
observed the accumulation of ARHGAP25 around the
freshly formed phagosomes.7 The localization of ARH-
GAP25 does not overlap with regions enriched in polymer-
ized actin (Figure 1), suggesting that local downregulation
of Rac activity impedes actin polymerization. In functional
studies downregulation of ARHGAP25 by siRNA in the
human model cell line PLB‐985 or in primary human
macrophages significantly increased, whereas its overex-
pression in COSphoxFcγR cells prevented, phagocytosis of
opsonized yeast particles.7 The effect depended on the
GAP activity of the construct. Interestingly, overexpression
of p50RhoGAP, another GAP acting on Rac, did not influ-
ence phagocytosis, whereas it prevented the formation of
lamellipodia as efficiently as did ARHGAP25. Again, the
data point to selective action of GAPs with similar sub-
strate specificity.
A detailed study was carried out subsequently by the
group of Sergio Grinstein in macrophages.8 In a systematic
screen, they eventually identified three Rho family GAPs—
ARHGAP12, ARHGAP25 and SH3BP1—that showed
PIP3‐dependent translocation to the forming phagosome,
and their downregulation significantly impaired FcγR‐
mediated phagocytosis of large particles. The fact that none
of these GAPs was essential for phagocytosis of small par-
ticles indicates different molecular organization of the
phagocytic process depending on the size of the particle to
be engulfed. Silencing of either of the three critical GAPs
on its own was able to drastically reduce phagocytosis of
large particles, suggesting a kind of sequential involvement
of the different GAPs, possibly in different molecular com-
plexes. These remain to be identified in future.
4 | DO GAPS ONLY TERMINATE
SMG‐DEPENDENT BIOLOGICAL
PROCESSES?
GAPs are regarded in general as terminators of smg‐orga-
nized cellular processes. In fact, the actual level of active,
GTP‐bound smg is the result of the balance of GEF and
GAP activity—complicated by binding of the GDP‐smg to
GDI and differences due to the prenylation state of the smg
(Figure 2). Genetic depletion or pharmacological inhibition
of RacGAPs resulted in enhancement of superoxide pro-
duction,15,20,26 suggesting that certain GAPs exert a consti-
tutive activity. Hence, physiological inhibition of a GAP
may just as well increase the amount of the active form of
the smg as activation of a GEF does. Moreover, simultane-
ous activation of GEF and inhibition of the corresponding
GAP can result in burst‐like activation of a smg at a speci-
fic location.
In case of neutrophil precursors, there is a nice example
in which alteration of a GAP activity initiates an important
Rac‐dependent biological function. Applying a newly
developed quantitative phosphoproteomic analysis, Leo
Wang and his colleagues identified ARHGAP25 as a pro-
tein that showed highly different phosphorylation profiles
in resting and mobilized hematopoietic stem and progenitor
cells (HSPC).27 They could also show that ARHGAP25
activity was essential for mobilization of hematopoietic
cells from the bone marrow. Our group revealed that
ARHGAP25 f-actin Merge
*
FIGURE 1 Localization of endogenous ARHGAP25 is opposite to filamentary actin around phagosomes. Human neutrophils isolated from
peripheral blood7 were centrifuged to 25 mm in diameter glass coverslips in 106/mL concentration. Then, pooled serum‐opsonized yeast particles
in 108/mL concentration were added to the neutrophils and coincubated for 2 min for phagocytosis. Then, cells were fixed with 4% v/v
paraformaldehyde for 10 min, permeabilized with 0.1% (v/v) Triton X‐100 for 5 min and stained with anti‐ARHGAP25 polyclonal antibody in
1:1000 dilution for 20 min at RT. Thereafter, staining with Alexa‐488‐anti‐rabbit IgG (in 1:1000 dilution) and in parallel with Alexa‐568‐
Phalloidin (in 1:500 dilution) was carried out for 20 min at RT. Microscope slides were analysed with Zeiss LSM710 confocal microscope,
equipped with a 63×/1.40 oil DIC M27 immersion objective. The optical section thickness was approx. 1 μm. Images were processed with Zeiss
LSM Image Browser acquisition software. Asterisk shows the phagocytosed yeast particle
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phosphorylation of the serine residue at position 363 in
ARHGAP25 specifically inhibits the GAP activity and in
this way promotes the prevalence of HSPC in the bone
marrow. Apparently, dephosphorylation and increased
ARHGAP25 activity contribute to cell mobilization from
the central hematopoietic organ.
Phosphorylation not only increases or decreases the
activity of certain GAPs, but in case of the double‐specifi-
city (Rac and Rho) GAP p190‐A (ARHGAP35), it also
changes the substrate specificity. The N‐terminal side of
the consensus GAP domain contains a polybasic region
that allows electrostatic binding to negatively charged
phospholipids. In this state, the protein has mostly RacGAP
activity. Within the polybasic region are three PKC phos-
phorylation sites. Phosphorylation of these serines reverts
the phospholipid binding and increases the RhoGAP activ-
ity of the protein.28,29 Opposing alteration of the Rac and
RhoGAP activity could be verified also in cellular func-
tions.30 In contrast, phosphorylation of four amino acids at
the C‐terminal end of p190‐A by GSK decreases both the
Rac and the RhoGAP activity of the protein.31,32 Although
the regulatory function could be demonstrated both with
human proteins and with murine cells, contribution of the
protein to integrin activation differs in human and murine
neutrophils.12,13
In addition to phosphorylation, GAP activity can be
altered in numerous other ways.33 Neutrophils are charac-
terized by a short lifetime (see Hellebrekers et al., in this
issue); hence, expression‐level regulation is not what one
would typically expect. Nevertheless, our preliminary
results indicate that the amount of mRNA coding for ARH-
GAP25 decreases following exposure to opsonized bacteria,
whereas in control cells, no significant change is observed
(Figure 3A,B). Detectable decrease in the protein level
accompanies the reduction of the coding mRNA
(Figure 3C,D), possibly contributing to the enhancement of
Rac activity under conditions in which increased cytoskele-
tal rearrangement is needed.
5 | ARE GAPS LONELY PLAYERS?
GAPs acting on Rho family smgs are present in every part
of the neutrophil. In cell fractionation assays, their effect
could be shown both in the membranous and in the cytoso-
lic fractions.9 In microscopic studies, we see evidence of
translocation of GAPs and selective association with the
plasma or intracellular membranes (as shown for ARH-
GAP25 above). However, in case of neutrophils, our
knowledge is poor on specific molecular complexes
composed of one or another Rho family GAP, although
the diverse domain structure of the proteins and examples
from other cell types predict a highly regulated molecular
organization.
One of the important but undecided questions is the fol-
lowing: What exactly do Rho family GAPs react with, the
free, uncomplexed smgGTP or smgGTP in complex with
its target molecule? Formulated in another way: Does GAP
really terminate a smgGTP‐dependent reaction or only pre-
vents the reactivation? Structural data obtained by X‐ray
diffraction are only available for the GAP domain of a few
Rho family GAP proteins, whereas folding and steric struc-
ture of the numerous other domains are unknown. Susan
Smith applied a modelling approach to get insight into this
problem. Using the known structure of the complexes of
Rac with its target protein p67phox and of Rac/Rho with the
GAP domain of several GAPs, she constructed a model of
the trimolecular complex. According to her analysis, the
Rac‐p67phox complex allows room to accommodate the
GAP domain; thus, a tripartite arrangement could be
PM
RacGDP
GDP GTP
Pi
RacGTP
Effector
GAPRacGDP
GDI
Inhibition
Inhibition
Activation
Activation
PM PM
GEF
FIGURE 2 The GTPase cycle of
smgs. PM: plasma membrane. Dashed lines
represent the effect of activation or
inhibition of GAPs and GEFs. Zigzag line
represents the prenylation of Rho family
smgs3
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possible.6 This model suggests that the GAP could have
access to RacGTP also in complex with its target protein—
at least with p67phox—and really terminate the Rac‐regu-
lated process. Experimental data showing an increase in
superoxide production upon inhibition of GAP action after
the assembly of the NADPH oxidase complex has occurred
are in agreement with the suggestions of this model.34
Moreover, the steric model of the tripartite complex
revealed an interface between the target protein p67phox
and the GAP protein,6 which could serve as selectivity fil-
ter for the interacting Rho family GAP. This situation
would then be similar to the tripartite structures described
for smg‐target protein‐GEF interactions.35,36
A few interesting examples in other cell types have
shown that the supramolecular organization of GAPs is
essential for their function. In case of epithelial junctions,
the term “zonular signalosome” has been introduced to
summarize the complex consisting of zonular proteins and
different RhoGEFs and RhoGAPs that assure the anchoring
of the junction as well as its contacts with the cytoskele-
ton.37 More direct data are available in neural studies.
Synaptogenesis of hippocampal neurons was shown to
depend both on the RacGEF Tiam1 and on the RacGAP
Bcr. A direct molecular interaction was revealed between
these two proteins that were essential in limiting Rac1 acti-
vation. Furthermore, proper development of synapses initi-
ated by EphB receptor critically depended on the
prevalence of and interaction between RacGEF and Rac-
GAP in the complex.38 Finally, in a very recent study, a
glimpse is offered into the dynamics of local changes of
Rho and Rho‐target activity via temporal shift of recruit-
ment of GEF‐H1 (ARHGEF2) and the RhoGAP Myo9b.39
6 | CONCLUSION
Although the verified enzymatic activity of GAPs consists
of acceleration of the GTP hydrolytic rate and thereby
attenuation of the biological function of the relevant smg,
these proteins play multifaceted roles in organization of
various cellular functions. Their contribution thus extends
far beyond the simple role of a “terminator,” and occasion-
ally, they may even function as “initiators.”
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FIGURE 3 Bacterial stimulus results in a reduced mRNA and protein level of ARHGAP25 in human neutrophils. Human neutrophils were
isolated from peripheral blood. Then, cells were stimulated with pooled serum‐opsonized S. aureus for the indicated time. Opsonization of the
bacteria and details of stimulation are described in.40 Total mRNA was isolated from the cells, and cDNA was prepared. Then, real‐time PCR
was carried out according to the protocol detailed in,41 with ARHGAP25‐specific primers and probe, and the cDNA as template. Panel A, shows
the results of control experiments, in which cells were treated only with serum, but without bacteria. Panel B, shows the results of experiments,
in which neutrophils were stimulated with opsonized bacteria. The number of independent experiments is given in the columns. Bars represent
the mean + SEM of the indicated independent experimental results. *: P<0.05. Panels C, D, ARHGAP25 protein amount is decreased in human
neutrophils treated with opsonized bacteria. Cells were stimulated with pooled serum‐opsonized S. aureus for the indicated time, as described
above. Then, cells were lysed, and SDS‐polyacrylamide gel electrophoresis and Western blot were carried out as described in.7 Western blot was
treated with anti‐ARHGAP25 polyclonal antibody in 1:1000 dilution and with anti‐β‐actin antibody in 1:10 000 dilution
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